Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Journal of Psychopharmacology (Oxford, England)
|
September 28, 2017
Blockade of dopamine D<sub>1</sub>-family receptors attenuates the mania-like hyperactive, risk-preferring, and high motivation behavioral profile of mice with low dopamine transporter levels
Morgane Milienne-Petiot, Lucianne Groenink, Arpi Minassian, et al.
Psychopharmacology
|
February 5, 2017
Brexpiprazole reduces hyperactivity, impulsivity, and risk-preference behavior in mice with dopamine transporter knockdown-a model of mania
Morgane Milienne-Petiot, Mark A Geyer, Jørn Arnt, et al.
Psychopharmacology
|
July 5, 2015
Modeling bipolar disorder in mice by increasing acetylcholine or dopamine: chronic lithium treats most, but not all features
Jordy van Enkhuizen, Morgane Milienne-Petiot, Mark A Geyer, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
September 15, 2018
Nicotine improves probabilistic reward learning in wildtype but not alpha7 nAChR null mutants, yet alpha7 nAChR agonists do not improve probabilistic learning
Morgane Milienne-Petiot, Kerin K Higa, Andrea Grim, et al.
Neuropharmacology
|
August 5, 2017
Modafinil improves attentional performance in healthy, non-sleep deprived humans at doses not inducing hyperarousal across species
Zackary A Cope, Arpi Minassian, Dustin Kreitner, et al.
Neuropharmacology
|
November 5, 2016
The effects of reduced dopamine transporter function and chronic lithium on motivation, probabilistic learning, and neurochemistry in mice: Modeling bipolar mania
Morgane Milienne-Petiot, James P Kesby, Mary Graves, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
July 10, 2014
Reduced dopamine transporter functioning induces high-reward risk-preference consistent with bipolar disorder
Jordy van Enkhuizen, Brook L Henry, Arpi Minassian, et al.
Behavioural Brain Research
|
September 15, 2022
Chronic methamphetamine exposure exerts few effects on the iTat mouse model of HIV, but blocks Tat expression-induced slowed reward retrieval
Jared W Young, Johnny A Kenton, Morgane Milienne-Petiot, et al.
Pharmacology, Biochemistry, and Behavior
|
December 3, 2022
iTat transgenic mice exhibit hyper-locomotion in the behavioral pattern monitor after chronic exposure to methamphetamine but are unaffected by Tat expression
Samantha Ayoub, Johnny A Kenton, Morgane Milienne-Petiot, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
September 6, 2020
Both HIV and Tat expression decrease prepulse inhibition with further impairment by methamphetamine
T Jordan Walter, Jared W Young, Morgane Milienne-Petiot, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Journal of Psychopharmacology (Oxford, England)
|
September 28, 2017
Blockade of dopamine D<sub>1</sub>-family receptors attenuates the mania-like hyperactive, risk-preferring, and high motivation behavioral profile of mice with low dopamine transporter levels
Morgane Milienne-Petiot, Lucianne Groenink, Arpi Minassian, et al.
Psychopharmacology
|
February 5, 2017
Brexpiprazole reduces hyperactivity, impulsivity, and risk-preference behavior in mice with dopamine transporter knockdown-a model of mania
Morgane Milienne-Petiot, Mark A Geyer, Jørn Arnt, et al.
Psychopharmacology
|
July 5, 2015
Modeling bipolar disorder in mice by increasing acetylcholine or dopamine: chronic lithium treats most, but not all features
Jordy van Enkhuizen, Morgane Milienne-Petiot, Mark A Geyer, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
September 15, 2018
Nicotine improves probabilistic reward learning in wildtype but not alpha7 nAChR null mutants, yet alpha7 nAChR agonists do not improve probabilistic learning
Morgane Milienne-Petiot, Kerin K Higa, Andrea Grim, et al.
Neuropharmacology
|
August 5, 2017
Modafinil improves attentional performance in healthy, non-sleep deprived humans at doses not inducing hyperarousal across species
Zackary A Cope, Arpi Minassian, Dustin Kreitner, et al.
Neuropharmacology
|
November 5, 2016
The effects of reduced dopamine transporter function and chronic lithium on motivation, probabilistic learning, and neurochemistry in mice: Modeling bipolar mania
Morgane Milienne-Petiot, James P Kesby, Mary Graves, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
July 10, 2014
Reduced dopamine transporter functioning induces high-reward risk-preference consistent with bipolar disorder
Jordy van Enkhuizen, Brook L Henry, Arpi Minassian, et al.
Behavioural Brain Research
|
September 15, 2022
Chronic methamphetamine exposure exerts few effects on the iTat mouse model of HIV, but blocks Tat expression-induced slowed reward retrieval
Jared W Young, Johnny A Kenton, Morgane Milienne-Petiot, et al.
Pharmacology, Biochemistry, and Behavior
|
December 3, 2022
iTat transgenic mice exhibit hyper-locomotion in the behavioral pattern monitor after chronic exposure to methamphetamine but are unaffected by Tat expression
Samantha Ayoub, Johnny A Kenton, Morgane Milienne-Petiot, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
September 6, 2020
Both HIV and Tat expression decrease prepulse inhibition with further impairment by methamphetamine
T Jordan Walter, Jared W Young, Morgane Milienne-Petiot, et al.
Page
of 1